Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,436,593
+$14,108,361 QoQ
Shares Held
120,325
+2793.8% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $7,059,039,871 across 32 Diagnostics & Research names. BLLN ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,957,066 | $1,482,554,608 | |
| 2 | DHR |
Danaher Corp /De/
|
5,364,861 | $1,021,898,721 | |
| 3 | A |
Agilent Technologies, Inc.
|
4,707,720 | $625,326,445 | |
| 4 | GH |
Guardant Health, Inc.
|
3,775,895 | $566,497,524 | |
| 5 | NTRA |
Natera, Inc.
|
1,720,152 | $466,935,259 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
738,708 | $388,885,438 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,949,797 | $376,739,772 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
252,137 | $322,107,537 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,436,593 | 120,325 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $328,232 | 4,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,695,315 | 20,715 | Shares | Defined | 2026-03-25 | |
| No filing history on record for this holder in this stock. | ||||||